Evidence map›Paper›PMID 41004570›Full record

ArticleScience advances2025

Repeated oral exposure to H5N1 influenza virus in pasteurized milk does not cause adverse responses to subsequent influenza infection.

Pamela H Brigleb, Ericka Kirkpatrick Roubidoux, Lauren Lazure, Brandi Livingston, Victoria A Meliopoulos, Bridgett Sharp, Tyler Ripperger, Shelby Patrick, Dorothea R Morris, Shaoyuan Tan and 1 more

Abstract read
In one paragraph

Article in Science advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Pamela H BriglebDepartment of Host Microbe Interactions, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.ORCID 0000-0002-7225-2608
Ericka Kirkpatrick RoubidouxDepartment of Host Microbe Interactions, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Lauren LazureDepartment of Host Microbe Interactions, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.ORCID 0009-0007-8429-0066
Brandi LivingstonDepartment of Host Microbe Interactions, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Victoria A MeliopoulosDepartment of Host Microbe Interactions, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.ORCID 0000-0003-1442-9177
Bridgett SharpDepartment of Host Microbe Interactions, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.ORCID 0000-0003-0370-4188
Tyler RippergerDepartment of Host Microbe Interactions, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.ORCID 0000-0003-1686-0147
Shelby PatrickDepartment of Host Microbe Interactions, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Dorothea R MorrisDepartment of Host Microbe Interactions, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.ORCID 0000-0003-1049-2208
Shaoyuan TanDepartment of Host Microbe Interactions, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Stacey Schultz-CherryDepartment of Host Microbe Interactions, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.ORCID 0000-0002-2021-727X

Funding

NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities75N93021C00016 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI WEBBY, RICHARD · 2021 to 2025
$91.4M
Training in the Design and Development of Infectious Disease TherapeuticsT32AI106700 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Richard E. Lee · 2015 to 2026
$2.1M
Impact of obesity on antiviral NK cell function and immune crosstalk with respiratory epithelial cells during influenza virus infectionF32AI183804 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI BRIGLEB, PAMELA · 2024 to 2025
$152k
NIAID NIH HHS F32 AI183804NIAID NIH HHS T32 AI106700NIH HHS 75N93021C00016
6 · The paper itself

Abstract

In March 2024, a highly pathogenic avian influenza H5N1 (HPAI) clade 2.3.4.4b virus was identified in US dairy cows, with spillover to cats, poultry, and humans. Up to 30% of commercial pasteurized milk tested contained viral genome copies. The impact of residual viral remnants on host immunity is unknown. Orally ingested proteins can stimulate gut-associated lymphoid tissues, potentially inducing tolerance and altering responses to later infection. We found that milk pasteurization fully inactivated pandemic H1N1 and bovine H5N1 influenza viruses yet preserved hemagglutinin (HA) protein integrity. In mice, repeated oral exposure to inactivated virus did not alter mortality after H5N1 virus challenge. Preliminary data showed that naïve mice exposed to improperly pasteurized milk containing live H5N1 virus developed lethal infection, whereas prior H1N1 infection conferred protection. Mice with preexisting H1N1 immunity remained protected when challenged with bovine H5N1 virus after exposure to H5N1 pasteurized in milk. These findings suggest that pasteurized milk containing inactivated H5N1 virus poses minimal health risks.

Indexed as

Influenza A Virus, H5N1 SubtypeInfluenza, HumanMilkOrthomyxoviridae InfectionsPasteurizationAdministration, OralAnimalsCattleFemaleHemagglutinin Glycoproteins, Influenza VirusHumansInfluenza A Virus, H1N1 SubtypeMiceHemagglutinin Glycoproteins, Influenza Virus

Identifiers

PMID41004570
PMCPMC12466813

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.